Utilization of Acid Suppression Medication in an Underserved Population
Autor: | Gabriel Soliman, Jose Barboza, Damaris Viera, Ariel Croker, Karim Hanna, Jennifer Acevedo-Giron, Simon Akhnoukh |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Cross-sectional study Gastrointestinal Diseases Population Disease Vulnerable Populations Underserved Population Internal medicine Surveys and Questionnaires Health care medicine Humans Medical prescription education Aged education.field_of_study business.industry General Medicine Middle Aged medicine.disease Malnutrition Cross-Sectional Studies Histamine H2 Antagonists Florida Female business Esophagitis |
Zdroj: | Southern medical journal. 113(3) |
ISSN: | 1541-8243 |
Popis: | Objectives Acid suppression therapy (AST), composed of proton pump inhibitors (PPIs), histamine-2 receptor blockers, and antacids, is one of the most common medication groups used in the United States. Long-term AST is concerning, however, because it is linked with an increased risk of community-acquired pneumonia, Clostridium difficile infections, bone fractures, and nutritional deficiencies. The potentially harmful biological and economic consequences associated with the improper use of acid suppression medications presents a great deal of risk to those in underserved communities. We sought to determine the prevalence of AST in an underserved population and the common diagnoses and symptoms associated with therapy. In addition, we studied the frequency of suboptimal usage of PPIs in an indigent care population and the potential factors related to high-risk behaviors. Methods The study was a cross-sectional study using a survey that was distributed to participants during their regularly scheduled visits to a public sector provider of health care for low-income patients. Results Of the 176 participants surveyed, 70 (40%) were using AST. Esophagitis and gastroesophageal reflux disease were the most prevalent in our sample population. PPIs were the most common acid suppression medication used in our population. Of those using PPIs, 85% were never instructed to cease use. Of the 27 patients with PPI prescriptions, 26 used it in a suboptimal manner, and of those without prescriptions, 7 used it in a suboptimal manner. Conclusions ASTs are prevalent in low-income populations, and patients are not being managed appropriately to minimize their risk for complications of AST. |
Databáze: | OpenAIRE |
Externí odkaz: |